• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C9缺陷型人血清的杀菌活性。

Bactericidal activity of C9-deficient human serum.

作者信息

Pramoonjago P, Kinoshita T, Hong K S, Takata-Kozono Y, Kozono H, Inagi R, Inoue K

机构信息

Department of Bacteriology, Osaka University Medical School, Japan.

出版信息

J Immunol. 1992 Feb 1;148(3):837-43.

PMID:1730876
Abstract

Escherichia coli B/SM, strain 1-1, was killed dose dependently by human hereditary C9-deficient serum (C9DHS), which was shown to contain no C9 Ag by an ELISA method. On the other hand, human hereditary C7-deficient serum did not kill the bacteria under similar conditions. The bactericidal activity of C9DHS was inhibited by rabbit anti-C5 antibody but not by murine anti-C9 mAb. The anti-C9 antibody decreased the bactericidal activity of normal human serum (NHS) to the level of that with C9DHS. Sheep anti-human lysozyme antibody did not affect the bactericidal activity of C9DHS or NHS even when added at more than twice the concentration required to block the serum lysozyme activity on Micrococcus luteus. After treatment with C9DHS and washing, surviving Escherichia coli were killed by C9, but not by lysozyme, transferrin, or both. Other strains of E. coli (K12 W3110, C600, and NIHJ) and Salmonella typhimurium (strain NCTC 74), all maintained in the laboratory, were also killed by C9DHS. However, pathogenic strains recently isolated from patients with traveler's diarrhea and some strains of S. typhimurium were resistant to both C9DHS and NHS, at least at the serum concentration tested. A concentration of 0.1 M Tris did not increase the susceptibility of serum-resistant strains of bacteria to C9DHS, but made one strain of S. typhimurium tested susceptible to NHS, but not to C9DHS. These results clearly showed that C9DHS kills bacteria that are sensitive to NHS through activation of C up to the step of C8 in the same way that C9-deficient C serum lyzed sensitized erythrocytes.

摘要

大肠杆菌B/SM 1-1菌株被人遗传性C9缺陷血清(C9DHS)以剂量依赖方式杀灭,ELISA法显示该血清不含C9抗原。另一方面,人遗传性C7缺陷血清在类似条件下未杀灭该细菌。C9DHS的杀菌活性被兔抗C5抗体抑制,但不被鼠抗C9单克隆抗体抑制。抗C9抗体将正常人血清(NHS)的杀菌活性降低至C9DHS的水平。羊抗人溶菌酶抗体即使以超过阻断对藤黄微球菌血清溶菌酶活性所需浓度两倍的量添加,也不影响C9DHS或NHS的杀菌活性。用C9DHS处理并洗涤后,存活的大肠杆菌被C9杀灭,但不被溶菌酶、转铁蛋白或两者共同杀灭。实验室保存的其他大肠杆菌菌株(K12 W3110、C600和NIHJ)以及鼠伤寒沙门氏菌(菌株NCTC 74)也被C9DHS杀灭。然而,最近从旅行者腹泻患者中分离出的致病菌株以及一些鼠伤寒沙门氏菌菌株至少在所测试的血清浓度下对C9DHS和NHS均有抗性。0.1 M Tris的浓度并未增加血清抗性细菌菌株对C9DHS的敏感性,但使所测试的一株鼠伤寒沙门氏菌对NHS敏感,但对C9DHS不敏感。这些结果清楚地表明,C9DHS通过将补体激活至C8步骤来杀灭对NHS敏感的细菌,方式与C9缺陷的补体血清裂解致敏红细胞相同。

相似文献

1
Bactericidal activity of C9-deficient human serum.C9缺陷型人血清的杀菌活性。
J Immunol. 1992 Feb 1;148(3):837-43.
2
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.细菌对补体介导杀伤作用的抗性机制研究。VI. IgG通过在C5裂解前的一个步骤发挥作用,提高C5b-9对大肠杆菌0111B4的杀菌效率。
J Immunol. 1983 Nov;131(5):2570-5.
3
Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.TraT蛋白(一种由R100因子在大肠杆菌中产生的抗补体蛋白)在血清抗性中的作用。
J Immunol. 1992 Feb 1;148(3):827-36.
4
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.细菌对补体介导杀伤的抗性机制研究。V. IgG和F(ab')2通过替代补体途径介导对大肠杆菌O111B4的杀伤,而不增加C5b-9沉积。
J Immunol. 1983 Nov;131(5):2563-9.
5
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli.补充补体成分C9可增强新生儿血清杀灭多种致病性大肠杆菌分离株的能力。
Pediatr Res. 1994 Apr;35(4 Pt 1):389-96.
6
Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.多聚体C9存在于鼠伤寒沙门氏菌细胞壁的独特位置的C5b-9沉积物中。
J Immunol. 1989 Jun 15;142(12):4450-7.
7
The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.大肠杆菌与正常人血清的相互作用:血清介导的脂多糖释放动力学及其与细菌杀伤的解离
J Immunol. 1986 Aug 15;137(4):1329-35.
8
Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.正常绵羊血清对革兰氏阴性菌的杀菌及调理活性
Am J Vet Res. 1975 Aug;36(08):1189-93.
9
Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.肝硬化患者血清对大肠杆菌的杀菌活性不足。
J Clin Invest. 1979 May;63(5):912-921. doi: 10.1172/JCI109391.
10
Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.针对淋球菌蛋白I的单克隆抗体在杀菌活性方面存在差异。
J Immunol. 1985 May;134(5):3411-9.

引用本文的文献

1
Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.补体介导的大肠杆菌J5中脂多糖释放及外膜损伤:对C9的需求
Immunology. 2001 Mar;102(3):365-72. doi: 10.1046/j.1365-2567.2001.01198.x.
2
C9 deficiency in a patient with poststreptococcal glomerulonephritis.一名患有链球菌感染后肾小球肾炎患者的C9缺陷。
Pediatr Nephrol. 1995 Dec;9(6):746-8. doi: 10.1007/BF00868729.